share_log

3M | 8-K: 3M Company Unaudited Pro Forma Condensed Consolidated Financial Statements

3M | 8-K: Current report

3M | 8-K：重大事件
SEC announcement ·  04/04 16:19
Moomoo AI 已提取核心訊息
On April 1, 2024, 3M Company completed the spin-off of its health care business, now known as Solventum Corporation, distributing 80.1% of Solventum's common stock to 3M shareholders. The distribution was effective at 3:30 a.m. Eastern Time on the same day. 3M stockholders received one share of Solventum for every four shares of 3M held as of March 18, 2024. Solventum's common stock is now independently listed on the New York Stock Exchange under the symbol 'SOLV'. The separation has led to the reclassification of Solventum as Discontinued Operations in 3M's financial statements, and 3M will measure its remaining 19.9% equity interest in Solventum at fair value. The unaudited pro forma condensed consolidated financial statements reflect the financial impact of the separation as if it had occurred at the beginning of the fiscal year 2021.
On April 1, 2024, 3M Company completed the spin-off of its health care business, now known as Solventum Corporation, distributing 80.1% of Solventum's common stock to 3M shareholders. The distribution was effective at 3:30 a.m. Eastern Time on the same day. 3M stockholders received one share of Solventum for every four shares of 3M held as of March 18, 2024. Solventum's common stock is now independently listed on the New York Stock Exchange under the symbol 'SOLV'. The separation has led to the reclassification of Solventum as Discontinued Operations in 3M's financial statements, and 3M will measure its remaining 19.9% equity interest in Solventum at fair value. The unaudited pro forma condensed consolidated financial statements reflect the financial impact of the separation as if it had occurred at the beginning of the fiscal year 2021.
2024年4月1日，3M公司完成了其醫療保健業務（現名爲Solventum Corporation）的分拆工作，向3M股東分配了Solventum80.1％的普通股。該分配於美國東部時間當天凌晨 3:30 生效。截至2024年3月18日，每持有四股3M股份，3M股東將獲得一股Solventum股份。Solventum的普通股現已在紐約證券交易所獨立上市，股票代碼爲 “SOLV”。此次分離導致Solventum在3M的財務報表中被重新歸類爲已終止業務，3M將按公允價值衡量其在Solventum剩餘的19.9％的股權。未經審計的簡明合併財務報表反映了分離的財務影響，就好像分離發生在2021財年初一樣。
2024年4月1日，3M公司完成了其醫療保健業務（現名爲Solventum Corporation）的分拆工作，向3M股東分配了Solventum80.1％的普通股。該分配於美國東部時間當天凌晨 3:30 生效。截至2024年3月18日，每持有四股3M股份，3M股東將獲得一股Solventum股份。Solventum的普通股現已在紐約證券交易所獨立上市，股票代碼爲 “SOLV”。此次分離導致Solventum在3M的財務報表中被重新歸類爲已終止業務，3M將按公允價值衡量其在Solventum剩餘的19.9％的股權。未經審計的簡明合併財務報表反映了分離的財務影響，就好像分離發生在2021財年初一樣。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息